Cancer Chemotherapy And Pharmacology

Journal Title：Cancer Chemotherapy And Pharmacology

Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.

《癌症化疗和药理学》是该领域的著名期刊，它涉及实验和临床层面的广泛药理学和肿瘤学问题。这种快速出版媒介的主要重点是新型抗癌药物、其实验筛选、临床前毒理学和药理学、单一和联合用药方式以及临床 I、II 和 III 期试验。它是药理学家和肿瘤学家的必读读物，记录了以下领域的研究结果：临床毒理学、药代动力学、药效学、药物相互作用以及癌症治疗策略中化疗的适应症。

Cancer Chemotherapy And Pharmacology创刊于1978年，由Springer Berlin Heidelberg出版商出版，收稿方向涵盖医学 - 药学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 约2.5月 ，影响因子指数2.7，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。